Management and outcomes after neoadjuvant treatment for locally advanced breast cancer in older versus younger women.
Caroline Wium HansenMarianne VogsenAnnette Raskov KodahlPublished in: Acta oncologica (Stockholm, Sweden) (2022)
Among women with LABC, women ≥70 years were less likely to receive neoadjuvant therapy according to guidelines. Only half of the patients ≥70 years reached the goal of surgery with curative intent, with no difference in 3-year OS and DFS between age groups.
Keyphrases
- rectal cancer
- end stage renal disease
- polycystic ovary syndrome
- lymph node
- locally advanced
- prognostic factors
- newly diagnosed
- ejection fraction
- minimally invasive
- chronic kidney disease
- peritoneal dialysis
- physical activity
- radiation therapy
- coronary artery bypass
- squamous cell carcinoma
- clinical practice
- stem cells
- insulin resistance
- pregnant women
- patient reported outcomes
- skeletal muscle
- replacement therapy
- young adults
- percutaneous coronary intervention
- patient reported